[go: up one dir, main page]

RU2016112046A - PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES - Google Patents

PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES Download PDF

Info

Publication number
RU2016112046A
RU2016112046A RU2016112046A RU2016112046A RU2016112046A RU 2016112046 A RU2016112046 A RU 2016112046A RU 2016112046 A RU2016112046 A RU 2016112046A RU 2016112046 A RU2016112046 A RU 2016112046A RU 2016112046 A RU2016112046 A RU 2016112046A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
prevention
complex treatment
oncological diseases
dry powders
Prior art date
Application number
RU2016112046A
Other languages
Russian (ru)
Inventor
Борис Львович Беньковский
Константин Валентинович Гайдуль
Владимир Александрович Козлов
Сергей Иванович Корнилов
Original Assignee
Борис Львович Беньковский
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Борис Львович Беньковский filed Critical Борис Львович Беньковский
Priority to RU2016112046A priority Critical patent/RU2016112046A/en
Publication of RU2016112046A publication Critical patent/RU2016112046A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (3)

1. Фармацевтическая композиция, обладающая противоопухолевым и антиметастатическим действием, представляющая собой смесь сухих порошков экстрактов корня куркумы, виноградных косточек, листьев зеленого чая, черного перца, капусты брокколи, а также сухих порошков арабиногалактана и дигидрокверцетина.1. A pharmaceutical composition having antitumor and antimetastatic action, which is a mixture of dry powders of extracts of turmeric root, grape seed, green tea leaves, black pepper, broccoli, as well as dry powders of arabinogalactan and dihydroquercetin. 2. Фармацевтическая композиция по п. 1, отличающаяся тем, что процентное содержание по массе сухих порошков экстрактов различных растений, а также арабиногалактана и дигидрокверцетина, может составлять от 0,5 до 90% от общей массы используемых ингредиентов в процессе производства фармацевтической композиции.2. The pharmaceutical composition according to claim 1, characterized in that the percentage by weight of dry powders of extracts of various plants, as well as arabinogalactan and dihydroquercetin, can be from 0.5 to 90% of the total weight of the ingredients used in the manufacturing process of the pharmaceutical composition. 3. Фармацевтическая композиция по п. 1, отличающаяся тем, что она может применяться в качестве дополнительного средства в целях профилактики и комплексной терапии различных онкологических заболеваний.3. The pharmaceutical composition according to claim 1, characterized in that it can be used as an additional tool for the prevention and complex treatment of various oncological diseases.
RU2016112046A 2016-03-29 2016-03-29 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES RU2016112046A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2016112046A RU2016112046A (en) 2016-03-29 2016-03-29 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016112046A RU2016112046A (en) 2016-03-29 2016-03-29 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES

Publications (1)

Publication Number Publication Date
RU2016112046A true RU2016112046A (en) 2017-10-04

Family

ID=60047587

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016112046A RU2016112046A (en) 2016-03-29 2016-03-29 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES

Country Status (1)

Country Link
RU (1) RU2016112046A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109395052A (en) * 2018-11-08 2019-03-01 武汉森澜生物科技有限公司 Composition and its preparation method and application for inhibiting growth of tumour cell

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109395052A (en) * 2018-11-08 2019-03-01 武汉森澜生物科技有限公司 Composition and its preparation method and application for inhibiting growth of tumour cell

Similar Documents

Publication Publication Date Title
HK1232147A1 (en) Cenicriviroc for the treatment of fibrosis
WO2016004068A8 (en) Hydrogel compositions comprising encapsulated cells and methods of use thereof
CN108026053A8 (en) Condensed glyoxaline compound as mIDH1 inhibitor
EP4248981A3 (en) Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract
WO2015120372A3 (en) Compositions and methods to inhibit ezh2 for the treatment of cardiovascular diseases
HK1257296A1 (en) Novel compounds and uses thereof
CL2017000475A1 (en) Compositions for cosmetic formulation comprising a mixture selected from murumuru butter, ucuuba butter, brazilian-nut oil, passion fruit oil, cupuassu butter, assai oil and/or nhandiroba oil and/or esters thereof, as well as the use of a mixture for the preparation of a cosmetic
EA201791009A1 (en) COMPOSITIONS CONTAINING CYCLOSPORIN
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
WO2016056026A3 (en) Synergistic composition for osteoarthritis
HK1247136A1 (en) Compositions comprising 15-hepe and methods of using the same
WO2016100615A3 (en) Methods and composition for neutralization of influenza
WO2016093554A3 (en) Novel 4-(aryl)-n-(2-alkoxythieno[3,2-b]pyrazin-3-yl)-piperazine-1-carboxamide derivative, and antiproliferative effect thereof
WO2016036324A3 (en) Novel plant functional activated nano vacc-fertiliceutical, and methods of preparation, formulation, dilution, and use thereof
RU2016112046A (en) PHARMACEUTICAL COMPOSITION FOR PREVENTION AND COMPLEX TREATMENT OF ONCOLOGICAL DISEASES
WO2015044961A3 (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide
WO2017168454A3 (en) Novel compounds as btk inhibitors
WO2016072392A8 (en) Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency
RU2016133264A (en) CATECHOLAMINE PRODUCT ACCELERATOR AND THERAPEUTIC AND PREVENTIVE MEANS AND THERAPEUTIC AND PREVENTIVE FOOD COMPOSITION FOR DISEASES CONDITIONED BY CATHEOLAMIN INSUFFICIENCY
EA202091561A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PHARMACEUTICALLY ACCEPTABLE ACID-ADDITIVE LENALIDOMIDE SALT
RU2016117460A (en) An agent with hypolipidemic, hepatoprotective and antioxidant effects
WO2016105035A3 (en) Anti-gout composition containing mixture extract of chrysanthemum indicum and cinnamomum cassia as active ingredient
WO2016032127A3 (en) Novel compounds having antioxidant and anti-inflammatory activities due to competition with lps for binding to tlr4, and medical use thereof
RU2017101522A (en) INGREDIENTS FOR DELAYED OXIDATION OF MILK FAT
KR20140105884A (en) The manufacturing method of salt toothpaste composition, and the salt toothpaste composition

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20180608